Pharmafile - Business Services News
The decision follows NICE’s rapid review of the drug and it’s earlier draft guidance in August.
MSD, known as Merck in the US, announced that their Phase III clinical study of letermovir, an investigational antiviral medicine, met its primary...
Oxford Genetics has moved its operations to the Medawar centre in the city, upscaling its infrastructure and staff in the process.
German drug maker Merck KgaA has announced that they are on track to achieve objectives up to the 2018 and has set objectives for 2022.
The company cites the rise of generic alternatives that are muscling in on its business as one of the reasons for the revision.
Research, headed by Dr Michael Kühn, at Mainz University, Germany, has developed a new targeted epigenetic approach for the treatment of leukaemia.
The FDA has enforced a ‘Class III’ recall of Sun’s anti-depressants over dissolution specifications
Phase III results for Novartis’ cancer drug Zykadia (ceritinib) have revealed it as more effective than chemo at halting progression of non-small-...
Company agrees settlement to US Department of Justice against claims it intentionally misclassified its epinephrine auto-injector under the Medicaid...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches
